Citations

Clear

4801 citation(s) found for "Yu, Jennifer".

A randomized controlled trial of routine financial toxicity screening via electronic patient-reported outcomes (AFT-39).
Blinder, Victoria , Deal, Allison M. , Ginos, Brenda, Jansen, Jennifer , Henson, Sydney, Carr, Philip, Rogak, Lauren J. , Weiss, Anna , Rapperport, Anna, Spears, Patricia A. , Gany, Francesca , Basch, Ethan , Deal, Allison , Jansen, Jennifer , Dueck, Amylou C. , Mazza, Gina L , Schrag, Deborah , Basch, Ethan

Mayo Clinic

Journal of Clinical Oncology | September 30, 2022 | Volume: 40 | Issue: 28_suppl | Pages: 180-180

10.1200/jco.2022.40.28_suppl.180 Get It

180 Background: Financial toxicity affects 20% of cancer survivors and is associated with decreased treatment adherence and poor clinical outcomes. No large-scale programs have been implemented to mitigate financial toxicity among patients undergoing cancer treatment. We evaluated the effect of monthly patient-reported financial toxicity screening as part of a larger digital monitoring intervention. Methods: PRO-TECT (AFT-39) is a cluster-randomized trial of patients undergoing systemic therapy for metastatic cancer. Practices were randomized 1:1 to digital symptom monitoring with patient-reported outcomes (“PRO practices”) or usual care (“control practices”). Digital monitoring consisted of between-visit online or automated telephone patient surveys containing symptom, functioning, and financial toxicity screening questions for up to one year, with automated alerts sent to practice nurses for concerning survey scores. Clinical team actions in response to alerts were not mandated. The primary outcome of this analysis was development or worsening of financial difficulties, assessed via the EORTC QLQ-C30 (“Has your physical condition or medical treatment caused you financial difficulties?”), at any time compared to baseline. A randomly selected subset of patients and nurses were interviewed about their experiences with the intervention. Results: 1,191 patients were enrolled (593 PRO; 598 control) at 52 US community oncology practices. Overall, 30.2% of patients treated at practices that received the intervention developed, or experienced worsening of, financial difficulties, compared to 39.0% of patients treated at control practices (p = 0.01). Patients and nurses interviewed stated that financial toxicity screening identified patients for financial counseling who otherwise would be reluctant to seek, or unaware of the availability of, assistance. Conclusions: Screening for financial toxicity as part of routine digital patient monitoring with PROs reduces the development, or worsening, of financial difficulties among patients undergoing systemic cancer therapy. Clinical trial information: NCT03249090.
Oncologist perspectives on tumor boards: Virtual meetings and EHR integration.
Arafat, Waddah , Wagner, Andrew J. , Martin, Daniel B., Sugalski, Jessica , Heinrichs, Tricia , Racz, Jennifer M. , Heinrichs, Tricia , Fu, Paul C. , Osterman, Travis , Tevaarwerk, Amyé

Mayo Clinic

Journal of Clinical Oncology | September 30, 2022 | Volume: 40 | Issue: 28_suppl | Pages: 46-46

10.1200/jco.2022.40.28_suppl.046 Get It

46 Background: Tumor boards (TBs) are considered a key component for ensuring high quality cancer care. However, little is known about TB operational aspects that impact effectiveness. We aimed to understand how TBs leverage Electronic Health Record (EHR) functionalities and how pandemic-driven transitions from in-person TBs to virtual TBs impacted TB quality and effectiveness. Methods: The National Comprehensive Cancer Network (NCCN) Oncology EHR Advisory Group formed a Workgroup to assess the current state of TBs, obtain providers’ views on ideal TB state, and develop recommendations for improving TB quality and effectiveness. The Workgroup surveyed providers in various specialties at 31 NCCN Member Institutions in March 2022. Results: 846 providers from 27 institutions responded to the survey (n = 76 respondents were excluded from analysis because they reported not participating in TBs). Almost all (n = 764/767, 99%) indicated that one or more participants always or frequently attended TB meetings virtually. When comparing (newly established) virtual to (pre-pandemic) in-person TBs, 69% indicated increased attendance at virtual TBs. 65% reported no change in case volume, and 56% reported unchanged discussion quality while 19% reported increased discussion quality when comparing virtual to in-person TB meetings. In regards to EHR integration, several gaps between current and ideal state were noted. For instance, 40% always or frequently added patients to the TB roster via the EHR, but 57% reported this functionality to be very important or important for TBs. Additionally, 53% always or frequently document TB recommendations within the EHR, while 87% indicated EHR documentation of recommendations as very important or important. Respondents reported that barriers to documentation include resource constraints, concerns with patient access to documentation, legal and liability concerns, and poor EHR functionality. Conclusions: Overall, the majority of responding providers reported virtual TBs to be at least similar in quality to in-person TB meetings. A major gap identified by this study is the lack of documentation of TB recommendations in the EHR. Workflows and EHR functionalities could be improved to fully optimize the EHR for TB management and documentation.[Table: see text]
Consensus-Based Recommendations on Priority Activities to Address Acute Kidney Injury in Children
Goldstein, Stuart L. , Akcan‐Arikan, Ayse , Alobaidi, Rashid, Bagshaw, Sean M. , Barhight, Matthew , Frazee, Erin N. , Bayrakçı, Benan , Bignall, O. N. Ray , Brophy, Patrick D. , Chanchlani, Rahul , Charlton, Jennifer R. , Conroy, Andrea L. , Deep, Akash , Dolan, Kristin , Fuhrman, Dana Y. , Gorga, Stephen M. , Ulrich, E , Iyengar, Arpana , Krawczeski, Catherine D. , Meigs, Leslie, Menon, Shina , Morgan, Jolyn, Morgan, Catherine , Mottes, Theresa , Neumayr, Tara M. , Ricci, Zaccaria , Selewski, David T. , Sutherland, Scott M. , Symons, Jordan M. , Tavares, Marcelo de Sousa , Vega, Molly Wong , Zappitelli, Michael , Kellum, John A. , Collaborative, Pediatric ADQI, Kellum, John A , Bagshaw, Sean M , Akcan-Arikan, Ayse , Menon, Shina , Askenazi, David J. , Bjornstad, Erica C. , Devarajan, Prasad , Gist, Katja M. , Greenberg, Jason Henry , Hasson, Denise Claire , Jetton, Jennifer G. , Soranno, Danielle E. , Starr, Michelle C. , Stanski, Natalja L. , Ronco, Claudio , Mehta, Ravindra L. , Ostermann, Marlies , Basu, Rajit K. , Collaborative, Pediatric ADQI

Mayo Clinic

JAMA Network Open | September 30, 2022 | Volume: 5 | Issue: 9 | Pages: e2229442

10.1001/jamanetworkopen.2022.29442 | PMID 36178697 Get It

Importance Increasing evidence indicates that acute kidney injury (AKI) occurs frequently in children and young adults and is associated with poor short-term and long-term outcomes. Guidance is required to focus efforts related to expansion of pediatric AKI knowledge. Objective To develop expert-driven pediatric specific recommendations on needed AKI research, education, practice, and advocacy. Evidence Review At the 26th Acute Disease Quality Initiative meeting conducted in November 2021 by 47 multiprofessional international experts in general pediatrics, nephrology, and critical care, the panel focused on 6 areas: (1) epidemiology; (2) diagnostics; (3) fluid overload; (4) kidney support therapies; (5) biology, pharmacology, and nutrition; and (6) education and advocacy. An objective scientific review and distillation of literature through September 2021 was performed of (1) epidemiology, (2) risk assessment and diagnosis, (3) fluid assessment, (4) kidney support and extracorporeal therapies, (5) pathobiology, nutrition, and pharmacology, and (6) education and advocacy. Using an established modified Delphi process based on existing data, workgroups derived consensus statements with recommendations. Findings The meeting developed 12 consensus statements and 29 research recommendations. Principal suggestions were to address gaps of knowledge by including data from varying socioeconomic groups, broadening definition of AKI phenotypes, adjudicating fluid balance by disease severity, integrating biopathology of child growth and development, and partnering with families and communities in AKI advocacy. Conclusions and Relevance Existing evidence across observational study supports further efforts to increase knowledge related to AKI in childhood. Significant gaps of knowledge may be addressed by focused efforts.
The accuracy of ten common resting metabolic rate prediction equations in men and women collegiate athletes
Fields, Jennifer B. , Magee, Meghan K., Jones, Margaret T. , Askow, Andrew T. , Camic, Clayton L., Luedke, Joel, Jagim, Andrew R , Askow, Andrew T , Jagim, Andrew R.

Mayo Clinic

European Journal of Sport Science | September 28, 2022 | Volume: 23 | Issue: 10 | Pages: 1973-1982

10.1080/17461391.2022.2130098 | PMID 36168819 Get It

ABSTRACTPredictive resting metabolic rate (RMR) equations are widely used to determine total daily energy expenditure (TDEE). However, it remains unclear whether these predictive RMR equations accurately predict TDEE in the athletic populations. The purpose of this study was to examine the accuracy of 10 commonly used RMR prediction equations (Cunningham, De Lorenzo, Freire, Harris‐Benedict, Mifflin St. Jeor, Nelson, Owen, Tinsley, Watson, Schofield) in collegiate men and women athletes. One‐hundred eighty‐seven National Collegiate Athletic Association Division III men (n = 97) and women (n = 90) athletes were recruited to participate in one day of metabolic testing. RMR was measured using indirect calorimetry and body composition was analyzed using air displacement plethysmography. A repeated measures ANOVA with Bonferroni post hoc analyses was selected to determine mean differences between measured and predicted RMR. Linear regression analysis was used to assess the accuracy of each RMR prediction method (p<0.05). All prediction equations significantly underestimated RMR (p<0.001), although there was no difference between the De Lorenzo and Watson equations and measured RMR (p = 1.00) for women, only. In men, the Tinsley and Freire equations were the most agreeable formulas with the lowest root‐mean‐square prediction error value of 404 and 412 kcals, respectively. In women, the De Lorenzo and Watson equations were the most agreeable equations with the lowest root‐mean‐squared error value of 171 and 211 kcals, respectively. The results demonstrate that such RMR equations may underestimate actual energy requirements of athletes and thus, practitioners should interpret such values with caution.
Dementia Care in the Last Year of Life: Experiences in a Community Practice and in Skilled Nursing Facilities
Bartley, Mairead M. , Manggaard, Jennifer M., Holland, Diane E. , Takahashi, Paul Y. , Bartley, Mairead M. , Fischer, Karen M.

Mayo Clinic

Journal of Palliative Care | September 23, 2022 | Volume: 38 | Issue: 2 | Pages: 135-142

10.1177/08258597221125607 | PMID 36148476 Get It

Objective People living with dementia often have high care needs at the end-of-life. We compared care delivery in the last year of life for people living with dementia in the community (home or assisted living facilities [ALFs]) versus those in skilled nursing facilities (SNFs). Methods A retrospective study was performed of older adults with a dementia diagnosis who died in the community or SNFs from 2013 through 2018. Primary outcomes were numbers of hospitalizations and emergency department visits in the last year of life. Secondary outcomes were completed advance care plans, hospice enrollment, time in hospice, practitioner visits, and intensive care unit admissions. Results Of 1203 older adults with dementia, 622 (51.7%) lived at home/ALFs; 581 (48.3%) lived in SNFs. At least 1 hospitalization was recorded for 70.7% living at home/ALFs versus 50.8% in SNFs ( P < .001), similar to percentages of emergency department visits (80.2% vs 58.0% of the home/ALF and SNF groups, P < .001). SNF residents had more practitioner visits than home/ALF residents: median (IQR), 9.0 (6.0-12.0) versus 5.0 (3.0-9.0; P < .001). No advance care plan was documented for 12.2% (n = 76) of the home/ALF group versus 4.6% (n = 27) of the SNF group ( P < .001). Nearly 57% of SNF residents were enrolled in hospice versus 68.3% at home/ALFs ( P < .001). The median time in hospice was 26.5 days in SNFs versus 30.0 days at home/ALFs ( P = .67). Conclusions Older adults with dementia frequently receive acute care in their last year of life. Hospice care was more common for home/ALF residents. Time in hospice was short.
Eosinophil Peroxidase Staining Enhances the Diagnostic Utility of the Cytosponge in Eosinophilic Esophagitis
Masuda, Mia Y. , Barshow, Suzanne , Garg, Shipra , Putikova, Arina, LeSuer, William E., Alexander, Jeffrey A. , Katzka, David A. , Dellon, Evan S. , Kita, Hirohito , Horsley‐Silva, Jennifer L. , Doyle, Alfred D. , Wright, Benjamin L. , Kita, H , Wright, Benjamin L

Mayo Clinic

Clinical and Translational Gastroenterology | September 22, 2022 | Volume: 13 | Issue: 11 | Pages: e00534

10.14309/ctg.0000000000000534 | PMID 36137185 Get It

INTRODUCTION: We aimed to assess the diagnostic utility of eosinophil peroxidase (EPX) staining on Cytosponge (CS) samples in eosinophilic esophagitis (EoE). METHODS: Esophageal biopsy (BX) samples from adult subjects with EoE were assessed using peak eosinophils per high-power field (eos/hpf), EPX, and the EoE histologic scoring system. EPX staining and eos/hpf were compared (BX vs CS). RESULTS: CS EPX positivity correlated with eos/hpf (CS [ r = 0.82, P < 0.0001]; BX [ r = 0.65, P < 0.0001]) and EoE histologic scoring system (grade [ r = 0.62, P < 0.00001]; stage [ r = 0.61, P < 0.0001]). CS EPX identified subjects with active EoE (area under the curve = 0.86, P < 0.0001). DISCUSSION: The correlation of CS EPX with eosinophilic inflammation and histologic disease severity supports its diagnostic utility in EoE.
Treatment of Nontuberculous Mycobacterial (NTM) Pulmonary Infection in the US Bronchiectasis and NTM Registry: Treatment Patterns, Adverse Events, and Adherence to American Thoracic Society/Infectious Disease Society of America Treatment Guidelines
Ku, Jennifer H , Henkle, Emily , Aksamit, Timothy R. , Winthrop, Kevin , BARKER, ALAN ROBERT , Brunton, Amanda E.

Mayo Clinic

Clinical Infectious Diseases | September 22, 2022 | Volume: 76 | Issue: 2 | Pages: 338-341

10.1093/cid/ciac788 | PMID 36134755 Get It

Abstract Among 1038 participants with pulmonary Mycobacterium avium complex and 120 with Mycobacterium abscessus enrolled in the US Bronchiectasis and NTM Research Registry, less than half received antibiotic therapy in the 24 months before registry enrollment, of which less than half were guideline based. Adverse effects occurred in 21% of therapy recipients, of whom 33% discontinued therapy.
Transfer learning identifies in vivo senescence heterogeneity and contributions to vascularization and matrix production across species and diverse pathologies
Stivers, Katlin B. , Gray-Gaillard, Elise , Ruta, Anna , Hamada, Naomi, Hamada, Masakazu , Trewartha, Shawn , Wolf, Matthew, Keerthivasan, Shilpa , Saux, Claude Le, Housseau, Franck , Deursen, Jan M. van , Pardoll, Drew, Elisseeff, Jennifer H. , Cherry, Christopher, Andorko, James I. , Krishnan, Kavita , Mejías, Joscelyn C. , Nguyen, Helen Hieu , Han, Jin , Hamada, Naomi, Hamada, Masakazu, Sturmlechner, Ines , Michel, John H. , Huyer, Locke Davenport , Tam, Ada J , Peña, Alexis N. , Fertig, Elana Judith , Baker, Darren J.

Mayo Clinic

No container title available | September 20, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-1847932/v1 Get It

Abstract Cellular senescence is a state of permanent growth arrest that plays an important role in wound healing, tissue fibrosis, and tumor suppression. Despite senescent cells’ (SnC) pathological role and therapeutic interest, their phenotype in vivo remains poorly defined. Here, we developed an in vivoderived senescence signature using a foreign body response (FBR) fibrosis model in a SnC reporter mouse. We identified pericytes and “cartilage-like” fibroblasts as senescent and defined cell typespecific senescence associated secretory phenotypes (SASP). Transfer learning and senescence scoring identified these two SnC populations along with endothelial and epithelial SnCs in new and publicly available murine and human data single cell RNAseq (scRNAseq) datasets from diverse pathologies. Signaling analysis uncovered crosstalk between SnCs and myeloid cells via an IL34- CSF1R-TGFßR signaling axis, contributing to tissue balance of vascularization and matrix production. Overall, our study provides a senescence signature and a computational approach that may be broadly applied to identify transcriptional profiles and SASP factors produced by SnCs that regulate tissue structure and pathology.
Comparable Outcomes for Bebtelovimab and Ritonavir-Boosted Nirmatrelvir Treatment in High-Risk Patients With Coronavirus Disease-2019 During Severe Acute Respiratory Syndrome Coronavirus 2 BA.2 Omicron Epoch
Hanson, Sara N. , Arndt, Richard , Speicher, Leigh L. , Seville, Teresa A, Hall, Scott T. , Pike, Marsha L., Heyliger, Alexander , Larsen, Jennifer J., Tulledge‐Scheitel, Sidna M. , Arndt, Richard F, Ganesh, Ravindra , Tulledge-Scheitel, Sidna M, Razonable, Raymund R. , O’Horo, John C. , Ganesh, Ravindra

Mayo Clinic

The Journal of Infectious Diseases | September 20, 2022 | Volume: 226 | Issue: 10 | Pages: 1683-1687

10.1093/infdis/jiac346 | PMID 36124696 Get It

Abstract The effectiveness of bebtelovimab in real-world settings has not been assessed. In this retrospective cohort study of 3607 high-risk patients, bebtelovimab was used more commonly than nirmatrelvir-ritonavir for treatment of coronavirus disease 2019 (COVID-19) among older patients, immunosuppressed patients, and those with multiple comorbid conditions. Despite its use in patients with multiple comorbid conditions, the rate of progression to severe disease after bebtelovimab (1.4% [95% confidence interval, 1.2%–1.7%]) was not significantly different from that for nirmatrelvir-ritonavir treatment (1.2% [.8%–1.5%]). Our findings support the emergency use authorization of bebtelovimab for treatment of COVID-19 during the Omicron epoch dominated by BA.2 and subvariants.
Tumor Microenvironment CD14+ Cells Correlate with Poor Overall Survival in Patients with Early-Stage Lung Adenocarcinoma
Withers, Sarah G., Bulur, Peggy A. , Dietz, Allan B. , Boland, Jennifer M. , Dietz, Allan B , Schenk, Erin L.

Mayo Clinic

Cancers | September 18, 2022 | Volume: 14 | Issue: 18 | Pages: 4501

10.3390/cancers14184501 | PMID 36139660 Get It

Patients with early-stage lung adenocarcinoma have a high risk of recurrent or metastatic disease despite undergoing curative intent therapy. We hypothesized that increased CD14+ cells within the tumor microenvironment (TME) could stratify patient outcomes. Immunohistochemistry for CD14 was performed on 189 specimens from patients with lung adenocarcinoma who underwent curative intent surgery. Outcomes and associations with clinical and pathologic variables were determined. In vitro studies utilized a coculture system to model the lung cancer TME containing CD14+ cells. Patients with high levels of TME CD14+ cells experienced a median overall survival of 5.5 years compared with 8.3 and 10.7 years for those with moderate or low CD14 levels, respectively (p < 0.001). Increased CD14+ cell tumor infiltration was associated with a higher stage at diagnosis and more positive lymph nodes at the time of surgery. This prognostic capacity remained even for patients with early-stage disease. Using an in vitro model system, we found that CD14+ cells reduced chemotherapy-induced cancer cell death. These data suggest that CD14+ cells are a biomarker for poor prognosis in early-stage lung adenocarcinoma and may promote tumor survival. CD14+ cell integration into the lung cancer TME can occur early in the disease and may be a promising new therapeutic avenue.